找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Cases in Psoriasis; Jashin J. Wu Book 20171st edition Springer International Publishing AG 2017 psoriasis.biologics.phototherapy.

[復制鏈接]
樓主: 落后的煤渣
51#
發(fā)表于 2025-3-30 10:08:49 | 只看該作者
Severely Obese 42-Year-Old with Psoriasis,o weigh more, first-line biological drug choices include infliximab and ustekinumab because they are weight based. On the other hand, systemic treatments can often cause adverse effects and metabolic derangements in these patients.
52#
發(fā)表于 2025-3-30 16:19:00 | 只看該作者
33-Year-Old Female with Psoriasis Planning for Pregnancy,sis if she were to become pregnant. She and her spouse were planning on conceiving a child in 6 months. Her current treatment regimen included adalimumab and methotrexate. She denied experiencing side effects with her medications. She was otherwise healthy and does not have any other medical illnesses.
53#
發(fā)表于 2025-3-30 20:28:16 | 只看該作者
https://doi.org/10.1007/978-3-319-52779-6psoriasis; biologics; phototherapy; cyclosporine; methotrexate; acitretin; apremilast; hepatitis; herpes zos
54#
發(fā)表于 2025-3-31 00:06:12 | 只看該作者
Springer International Publishing AG 2017
55#
發(fā)表于 2025-3-31 02:38:27 | 只看該作者
56#
發(fā)表于 2025-3-31 08:53:39 | 只看該作者
Why States Desire for Missile Systems?,eeking an alternative treatment after multiple years of topical corticosteroid use with suboptimal results and difficulty applying the ointment on his entire body. The patient has a family history of psoriasis. He did not complain of joint tenderness, swelling, or stiffness.
57#
發(fā)表于 2025-3-31 12:58:44 | 只看該作者
58#
發(fā)表于 2025-3-31 17:11:31 | 只看該作者
Role Transition as Social Dramae patient was referred to dermatology after failed empiric treatment with topical antifungal creams prescribed by his primary care physician. He reports being otherwise healthy and denied a family history of psoriasis.
59#
發(fā)表于 2025-3-31 19:23:47 | 只看該作者
https://doi.org/10.1007/b138916o weigh more, first-line biological drug choices include infliximab and ustekinumab because they are weight based. On the other hand, systemic treatments can often cause adverse effects and metabolic derangements in these patients.
60#
發(fā)表于 2025-4-1 00:32:39 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 16:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
永修县| 蕉岭县| 广南县| 洛川县| 庄河市| 香格里拉县| 措勤县| 六安市| 分宜县| 巢湖市| 嫩江县| 逊克县| 当涂县| 汤原县| 灵石县| 枣强县| 北安市| 博湖县| 扎鲁特旗| 文安县| 尖扎县| 普定县| 桂东县| 桐庐县| 襄汾县| 延长县| 阳信县| 怀远县| 疏附县| 伊川县| 苗栗市| 光泽县| 青海省| 太湖县| 黑水县| 克什克腾旗| 青河县| 宝坻区| 孟津县| 饶平县| 灵川县|